Advanced glycation end products (AGEs) are formed in non-enzymatic reaction, oxidation,
rearrangement and cross-linking between the active carbonyl groups of reducing sugars …

Alzheimer's disease (AD) is characterized by a chronic and progressive neurodegenerative
process resulting from the intracellular and extracellular accumulation of fibrillary proteins …

Alzheimer's disease (AD) currently presents one of the biggest healthcare issues in the
developed countries. There is no effective treatment capable of slowing down disease …

None of the proposed mechanisms of Alzheimer's disease (AD) fully explains the distribution
patterns of the neuropathological changes at the cellular and regional levels, and their …

Symptoms of cognitive dysfunction like memory loss, poor concentration, impaired learning
and executive functions are characteristic features of both schizophrenia and Alzheimer's …

Quercetin has demonstrated antioxidant, anti-inflammatory, hypoglycemic, and
hypolipidemic activities, suggesting therapeutic potential against type 2 diabetes mellitus …

As indicated by its title, this monograph deals chiefly with morphologically recognizable
deviations from the normal anatomical condition of the human CNS. The AD-associated …

Alzheimer's disease (AD) is the most devastating neurodegenerative disorder affecting the
elderly. The exact pathology of AD is not yet fully understood and several hallmarks such as …

Alzheimer's disease (AD) is a progressive disease and one of the most common forms of
neurodegenerative disorders. Emerging evidence is supporting the use of various strategies …

Abstract Purpose of Review To explore the most recent developments in the effective
diagnosis and treatment of neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) …